AI and Data Leaders NVIDIA, AMD, Snowflake, and Databricks Invest in Uniphore’s Series F to Accelerate Its Leadership in Business AI
22.10.2025 13:30:00 CEST | Business Wire | Press Release
Uniphore, the Business AI company, today announced the close of its $260 million Series F round. NVIDIA, AMD, Snowflake, and Databricks invested in the round and were joined by financial and sovereign investors including NEA, March Capital, BNF Capital, National Grid Partners, and Prosperity7 Ventures. The new capital will accelerate innovation on its AI and data platform – Business AI Cloud – while deepening its ecosystem.
“Our Series F raise marks an exciting milestone for Uniphore. It is unlike most fundraises because, in addition to top-tier financial investors, we are joined by the world’s top AI and data companies,” said Umesh Sachdev, Co-founder and CEO, Uniphore. “This unique combination of capital and strategic alignment validates Uniphore’s position as the Business AI leader. We are seeing exponential adoption from Fortune 500 and other large companies, and this investment allows us to deliver even greater impact and accelerate innovation on behalf of our customers worldwide.”
Uniphore’s Series F was priced at $2.5 billion, reflecting the company’s ability to enable large businesses to realize the true value of AI – by delivering the personalization and ease of use that business users expect, with the enterprise-grade security, governance, and scalability that IT demands. This balance of usability and rigor unlocks AI’s power, fueling transformation and driving meaningful outcomes. Uniphore’s Business AI Cloud is the only sovereign, composable, and secure AI platform.
“This investment is an unprecedented validation of Uniphore’s position at the center of enterprise AI infrastructure,” said Gerry Murray, Research Director at IDC. “It signals broad consensus around a critical enabling layer – infrastructure that can securely connect data, knowledge, models, and agents across ecosystems.”
Accelerating Business AI Adoption
The investment from NVIDIA, AMD, Snowflake, and Databricks strengthens the Business AI Cloud for the over 2,000 global businesses that trust Uniphore to drive business outcomes, including many of the Fortune 500.
Uniphore’s growth is fueled by broad adoption of real-world and proven use cases with the Business AI Cloud:
- KPMG is working with Uniphore to help improve efficiency in different functions like procurement, workforce, and finance. By building AI agents on Uniphore's Business AI Cloud, KPMG can deliver increased value to clients across banking, insurance, energy, and other regulated industries. "Uniphore is quickly becoming an important player in AI – and we are thrilled to be working with them to democratize business knowledge into AI transformation to drive real outcomes for our clients. We are aligned with Uniphore’s vision for AI as a transformative force for business,” said Prasad Jayaraman, Advisory Principal at KPMG.
- Konecta uses Uniphore’s Business AI Cloud to codify operational expertise into a reusable library of prebuilt and custom agents for multilingual service, QA automation, agent coaching, and workflow orchestration. The result is faster resolutions, higher consistency, and centralized governance that meets CIO requirements across clients and regions. “Uniphore's Business AI Cloud helps us turn Konecta’s operational know-how into AI that scales,” said Oscar Vergé, Chief AI Deployment Officer. “On their platform, we are launching a library of prebuilt and custom agents for multilingual service, QA automation, agent coaching, and workflow orchestration. Clients get quicker resolutions, higher consistency, and the control their CIOs require.”
- Additional Uniphore clients across industries like Allstate, The Washington Post, Priceline, Atlassian, Bloomberg Media, Dell, and Skechers use Uniphore to drive growth, improve efficiency, and design personalized customer experiences.
“We see Uniphore as a leader in business AI, enabling an agentic enterprise,” said Hemant Dhulla, Vice President of NVIDIA AI Software. “By combining a sovereign and secure approach with seamless model orchestration and rapid deployment of AI agents, Uniphore is helping organizations unlock meaningful business outcomes, while maintaining control of their data and workflows.”
“Uniphore’s Business AI Cloud delivers the performance, efficiency, and security enterprises require,” said Dan McNamara, SVP and GM, Server, HPC and Enterprise AI, AMD. “As a leader in business AI, Uniphore has a strong track record of enabling Fortune 500 customers to move from AI pilots to production at scale.”
“Our investment in Uniphore is about bringing powerful agentic AI directly to our customers' data. By supporting Snowflake natively, Uniphore enables businesses to securely automate complex workflows, helping them realize value faster without ever moving their data,” said Harsha Kapre, Head of Snowflake Ventures.
“Our customers want to move generative AI apps and agents from proofs-of-concept to full-scale deployment without friction,” said Andrew Ferguson, Vice President of Databricks Ventures. “Uniphore’s Business AI Cloud helps organizations streamline data access, model interoperability, and agent orchestration, and ultimately turn AI initiatives into real business outcomes.”
“Uniphore’s Business AI Cloud brings open model choice, data sovereignty, and agentic automation together so enterprises can move from pilot to production fast,” said Abhishek Shukla, Managing Director at Prosperity7 US. “We are investing to support a platform that delivers governed AI at a global scale and measurable business results.”
NEA, March Capital, and National Grid Partners increased their investment based on continued market-leading growth, consistent execution, and confidence in Uniphore’s Business AI platform vision.
“We believe Uniphore is a generational company in AI with the platform and team to lead this market,” said Scott Sandell, Executive Chairman and CIO at NEA. “We have seen large businesses move from AI pilots to production in weeks – not months – with strong governance, and are excited to invest in Uniphore’s continued growth in this latest round.”
“Uniphore is delivering one of the fastest ramps we have seen in AI for businesses,” said Sumant Mandal, Co-founder and Managing Partner at March Capital. “Adoption of the Business AI Cloud is accelerating across the Fortune 500 with expanding use cases. Its open and composable design lets customers start fast and scale safely, and we are excited to back this team as they build a category leader.”
Recent milestones include the launch of the Business AI Cloud in spring 2025 and the acquisitions of ActionIQ and Infoworks, and the announced acquisitions of Orby AI and Autonom8. These announced acquisitions position Uniphore at the forefront of AI talent and support new outcomes for its clients – helping business users and CIOs adopt AI faster and more easily automate tasks with AI that is trained on enterprise data. Together, they strengthen Uniphore’s end-to-end approach to Business AI, which enables customers to keep their existing models and data infrastructure, work with current tech systems, and meet security and compliance requirements.
About Uniphore
Uniphore is the Business AI Company that unlocks the agentic enterprise with a complete, composable AI platform spanning agents, models, knowledge, and data. Its platform, the Business AI Cloud, bridges the AI divide between consumer AI and enterprise AI – combining the simplicity of consumer AI with the rigor, security, and scalability required for the enterprise. Uniphore allows business users to effortlessly harness AI and deliver results immediately, while providing CIOs the foundation to deliver powerful AI applications that are embedded into workflows trained on enterprise data. Trusted by more than 2,000 businesses globally, recognized by Gartner, Forrester, and listed on the Deloitte Fast 500, Uniphore delivers on the promise of AI as a transformative force for business. Learn more at www.uniphore.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251022873803/en/
Contacts
Media Contact:
Michael Trapani
Vice President of Global Marketing, Uniphore
(631) 560-8895
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom